External Ventricular Drain Placement Using Active Augmented Reality Guidance

Operative Neurosurgery 30:414–421, 2026

This technical note presents a proof-of-concept augmented reality (AR) system that guides external ventricular drain (EVD) placement by integrating cloud-based automatic CT segmentation, PACS compatibility, trajectory planning, point-based image-to-patient registration, and real-time 3D AR guidance via an AR head-mounted display. The low-cost, end-to-end workflow and universal tracking tools aim to reduce attention shifts and improve accessibility compared with conventional neuronavigation.

The system was tested in a phantom study with 29 AR-guided EVD insertions by neurosurgical clinicians, yielding 69% optimal placements (Kakarla grade 1), a mean distance-to-target of 9.49 mm, mean angular deviation of 9.20°, an FRE of 4.00 mm, and mean procedural time of 22:45. Authors identify human–computer interaction, tracking fidelity, registration accuracy, and procedural time as primary areas for refinement before clinical adoption.

Augmented Reality (AR) Guidance: A low-cost, end-to-end AR system was developed for external ventricular drain (EVD) placement, integrating real-time 3D guidance, automated CT segmentation, and compatibility with standard hospital PACS infrastructure, all visualized through AR head-mounted displays (AR-HMDs).

Workflow Components: The system includes cloud-based image storage, automatic segmentation, trajectory planning, point-based image-to-patient registration, and real-time EVD tracking, aiming to reduce attention shifts and improve procedural integration.

Proof-of-Concept Results: In simulated procedures on anatomical phantoms with small ventricles, 69% of placements were optimal (Kakarla 1), with a mean distance to target of 9.49 mm and mean angular deviation of 9.20°, but accuracy is not yet at the level of best clinical standards.

Procedural Time: The mean workflow duration was nearly 23 minutes, which is longer than acceptable for emergency EVD placements, with most of the added time attributed to trajectory planning, marker attachment, and image-to-patient registration.

Usability and Interface Challenges: Users experienced difficulties with human-computer interaction, including issues with holographic controls, visual clutter, and marker tracking, which impacted both speed and accuracy.

Affordability and Accessibility: The AR-HMD system (approx. $4950) is significantly less expensive than traditional neuronavigation systems, potentially increasing access to advanced guidance in resource-limited settings

Classification and Analysis of the Errors in Neuronavigation

Neurosurgery 68:1131–1143, 2011 DOI: 10.1227/NEU.0b013e318209cc45

There are many different types of errors in neuronavigation, and the reasons and results of these errors are complex. For a neurosurgeon using the neuronavigation system, it is important to have a clear understanding of when an error may occur, what the magnitude of it is, and how to avoid it or reduce its influence on the final application accuracy.

In this article, we classify all the errors into 2 groups according to the working principle of neuronavigation systems. The first group contains the errors caused by the differences between the anatomic structures in the images and that of the real patient, and the second group contains the errors occurring in transforming the position of surgical tools from the patient space to the image space. Each group is further divided into 2 subgroups.

We discuss 16 types of errors and classify each of them into one of the subgroups. The classification and analysis of these errors should help neurosurgeons understand the power and limits of neuronavigation systems and use them more properly.

Clinical Motor Outcome of Bilateral Subthalamic Nucleus Deep-Brain Stimulation for Parkinson’s Disease Using Image-Guided Frameless Stereotaxy

Neurosurgery 67:1088–1093, 2010 DOI: 10.1227/NEU.0b013e3181ecc887

Image-guided neuronavigation has largely replaced stereotactic frames when precise, real-time anatomic localization is required during neurosurgical procedures. However, some procedures, including placement of deep-brain stimulation (DBS) leads for the treatment of movement disorders, are still performed using frame-based stereotaxy. Despite the demonstration of comparable accuracy between frame-based and ‘‘frameless’’ image-guided approaches, the clinical efficacy of frameless DBS placement has never been reported.

OBJECTIVE: To analyze the outcomes of subthalamic nucleus (STN) DBS using the frameless technique for the treatment of Parkinson’s disease (PD).

METHODS: Of 31 subjects (20 men) with PD for 10 6 4 years, 28 had bilateral STN DBS and 3 had unilateral STN DBS. The Unified Parkinson’s Disease Rating Scale (UPDRS) motor scale (III) and total medication doses were assessed before surgery on and off medication and off medication/ON DBS (off/ON) after 6 to 12 months of STN DBS.

RESULTS: There was a 58% improvement from bilateral STN DBS in the UPDRS III (40 6 16 preoperatively off, 17 6 11 off/ON) 9.6 6 1.9 months after surgery (P , .001). This compared favorably with the published outcomes using the frame-based technique. All motor subscores improved significantly (P , .01). The mean reduction in medication was 50%. No intraoperative complications occurred, but one subject with hypertension died of a delayed hemorrhage postoperatively. Two subjects developed postoperative infections that required lead removal and antibiotics.

CONCLUSIONS: Bilateral STN DBS for PD performed by an experienced team using a frameless approach results in outcomes comparable to those reported with the use of the frame-based technique.